GraniteShares YieldBOOST HIMS ETF (HMYY)
20.85
0.00 (0.00%)
USD |
NASDAQ |
Dec 24, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 1.07% | 0.32% | 831197.0 | -- |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | -- | -- | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to achieve 2 times (200%) the income generated from selling options on Hims & Hers Health, Inc.’s common stock by selling options on leveraged exchange-traded funds designed to deliver 2 times (200%) the daily performance of the Underlying Stock and to gain exposure to the performance of the Underlying Leveraged ETF, subject to a cap on potential investment gains. The fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | -- |
| Broad Asset Class | Nontraditional Equity |
| Broad Category | Equity |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | GraniteShares Advisors |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 25, 2025.
Asset Allocation
As of December 19, 2025.
| Type | % Net |
|---|---|
| Cash | 105.7% |
| Stock | -5.74% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The investment seeks to achieve 2 times (200%) the income generated from selling options on Hims & Hers Health, Inc.’s common stock by selling options on leveraged exchange-traded funds designed to deliver 2 times (200%) the daily performance of the Underlying Stock and to gain exposure to the performance of the Underlying Leveraged ETF, subject to a cap on potential investment gains. The fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | -- |
| Broad Asset Class | Nontraditional Equity |
| Broad Category | Equity |
| Global Peer Group | Alternative Equity Leveraged |
| Peer Group | Equity Leverage Funds |
| Global Macro | Alternative Equity |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | GraniteShares Advisors |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |